# EDGAR Filing Document

**Accession Number:** 0001581178
**File Stem:** 0001171843-26-003785
**Filing Date:** 2026-5
**Character Count:** 3755
**Document Hash:** 9c7eaf97006d868a21f850e2835090c2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001171843-26-003785.hdr.sgml**: 20260529

**ACCESSION NUMBER**: 0001171843-26-003785

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20260528

**FILED AS OF DATE**: 20260529

**DATE AS OF CHANGE**: 20260529

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** EUPRAXIA PHARMACEUTICALS INC.
- **CENTRAL INDEX KEY:** 0001581178
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41923
- **FILM NUMBER:** 261042103

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 2198 YUKON STREET
- **CITY:** VANCOUVER
- **PROVINCE COUNTRY:** A1
- **ZIP:** V5Y 3P1
- **BUSINESS PHONE:** 250-590-3968

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 2198 YUKON STREET
- **CITY:** VANCOUVER
- **PROVINCE COUNTRY:** A1
- **ZIP:** V5Y 3P1

**UNITED STATES**<br> **SECURITIES AND EXCHANGE COMMISSION**<br> **Washington, D.C. 20549**

**Form 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of May 2026**

Commission File Number: **001-41923**

**EUPRAXIA PHARMACEUTICALS INC.**<br> (Exact name of Registrant as specified in its charter)

**N/A**<br> (Translation of Registrant's name)

**2198 Yukon Street**

**Vancouver, British Columbia, Canada V5Y 3P1**

**Telephone: (250) 590-3968**<br> (Address and telephone number of registrant's principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☐ Form 40-F ☒

**DOCUMENTS INCLUDED AS PART OF THIS REPORT**

---

| | |
|:---|:---|
| **Exhibit** |  |
| [99.1](exh_991.htm) | [Confirmation of proxy-related materials mailing](exh_991.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **EUPRAXIA PHARMACEUTICALS INC.** | **EUPRAXIA PHARMACEUTICALS INC.** |
| Date: May 28, 2026 | By: | <u>/s/ Alex Rothwell</u> |
|  |  | Name: Alex Rothwell |
|  |  | Title: Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

![](tmx.jpg)

#### TSX TRUST COMPANY

#### VIA ELECTRONIC TRANSMISSION
May 28, 2026

#### TO ALL APPLICABLE EXCHANGES AND COMMISSIONS:

---

| | |
|:---|:---|
| **RE:** | &nbsp;&nbsp;&nbsp;&nbsp;**EUPRAXIA PHARMACEUTICALS INC.** |

---

We are pleased to confirm that copies of the following proxy-related materials were mailed on May 27, 2026 to the Registered Securityholders and to the ESP Holders:

1 Proxy with Request for Financial Statements - Registered Securityholders

---

| | |
|:---|:---|
| 2 | Voting Instruction Form - ESP Holders |

---

3 Notice of Meeting Combined with Information Circular (Including Virtual Meeting Guide)

4 Proxy Return Envelope

Yours truly,

**TSX Trust Company**

---

| | | | |
|:---|:---|:---|:---|
| <br> **VANCOUVER**<br> 2310 - 733 Seymour Street,<br> Vancouver, BC V6B 0S6<br>**T** 604 689-3334 | <br> **CALGARY**<br> 300-5th Avenue SW, 10th floor<br> Calgary, AB T2P 3C4<br>**T** 403 218-2800 | <br> **TORONTO**<br> 301 - 100 Adelaide Street West<br> Toronto ON M5H 4H1<br>**Toll Free** 1-866-600-5869<br> **T** 416 361-0930 | <br> **MONTRÉAL**<br> 1800 - 1190, avenue des<br> Canadiens-de-Montréal, C. P. 37<br> Montréal (Québec) H3B 0G7<br>**T** 514 395-5964 |

---